HERBALIFE LTD (HLF) Fundamental Analysis & Valuation

NYSE:HLF • KYG4412G1010

15.77 USD
-0.62 (-3.78%)
Last: Mar 11, 2026, 02:00 PM

This HLF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

HLF gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. While HLF is still in line with the averages on profitability rating, there are concerns on its financial health. HLF scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. HLF Profitability Analysis

1.1 Basic Checks

  • In the past year HLF was profitable.
  • In the past year HLF had a positive cash flow from operations.
  • HLF had positive earnings in each of the past 5 years.
  • In the past 5 years HLF always reported a positive cash flow from operatings.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • HLF has a Return On Assets of 8.19%. This is in the better half of the industry: HLF outperforms 72.97% of its industry peers.
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROIC N/A
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • HLF has a better Profit Margin (4.53%) than 67.57% of its industry peers.
  • HLF's Profit Margin has declined in the last couple of years.
  • In the last couple of years the Operating Margin of HLF has declined.
  • HLF has a Gross Margin of 77.87%. This is amongst the best in the industry. HLF outperforms 86.49% of its industry peers.
  • In the last couple of years the Gross Margin of HLF has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 4.53%
GM 77.87%
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. HLF Health Analysis

2.1 Basic Checks

  • HLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HLF has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HLF has less shares outstanding
  • Compared to 1 year ago, HLF has an improved debt to assets ratio.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • HLF has an Altman-Z score of 1.16. This is a bad value and indicates that HLF is not financially healthy and even has some risk of bankruptcy.
  • HLF has a Altman-Z score (1.16) which is in line with its industry peers.
  • HLF has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as HLF would need 7.88 years to pay back of all of its debts.
  • HLF has a Debt to FCF ratio (7.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Altman-Z 1.16
ROIC/WACCN/A
WACC9.14%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • HLF has a Current Ratio of 1.13. This is a normal value and indicates that HLF is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.13, HLF is doing worse than 75.68% of the companies in the same industry.
  • HLF has a Quick Ratio of 1.13. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLF has a Quick ratio of 0.62. This is in the lower half of the industry: HLF underperforms 72.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. HLF Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.67% over the past year.
  • The earnings per share for HLF have been decreasing by -10.16% on average. This is quite bad
  • The Revenue has been growing slightly by 0.89% in the past year.
  • The Revenue has been decreasing by -1.89% on average over the past years.
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%

3.2 Future

  • Based on estimates for the next years, HLF will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.82% on average per year.
  • The Revenue is expected to grow by 4.29% on average over the next years.
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.67%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. HLF Valuation Analysis

4.1 Price/Earnings Ratio

  • HLF is valuated cheaply with a Price/Earnings ratio of 7.40.
  • Based on the Price/Earnings ratio, HLF is valued cheaper than 89.19% of the companies in the same industry.
  • HLF is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 6.13, the valuation of HLF can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, HLF is valued cheaper than 94.59% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. HLF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.4
Fwd PE 6.13
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, HLF is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA N/A
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • HLF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HLF's earnings are expected to grow with 17.82% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y17.82%
EPS Next 3YN/A

0

5. HLF Dividend Analysis

5.1 Amount

  • No dividends for HLF!.
Industry RankSector Rank
Dividend Yield 0%

HLF Fundamentals: All Metrics, Ratios and Statistics

HERBALIFE LTD

NYSE:HLF (3/11/2026, 2:00:10 PM)

15.77

-0.62 (-3.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners102.08%
Inst Owner Change3.28%
Ins Owners1.99%
Ins Owner Change0.8%
Market Cap1.63B
Revenue(TTM)5.04B
Net Income(TTM)228.30M
Analysts77.78
Price Target17.34 (9.96%)
Short Float %8.47%
Short Ratio4.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.93%
Min EPS beat(2)4.47%
Max EPS beat(2)7.39%
EPS beat(4)4
Avg EPS beat(4)30.94%
Min EPS beat(4)4.47%
Max EPS beat(4)59.17%
EPS beat(8)8
Avg EPS beat(8)40.78%
EPS beat(12)9
Avg EPS beat(12)22.69%
EPS beat(16)13
Avg EPS beat(16)25.36%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)2.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)2.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)6
Avg Revenue beat(12)-0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)17.24%
PT rev (3m)75.86%
EPS NQ rev (1m)-13.78%
EPS NQ rev (3m)-13.78%
EPS NY rev (1m)-2.76%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)1.42%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)1.65%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 7.4
Fwd PE 6.13
P/S 0.32
P/FCF 6.45
P/OCF 4.89
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.13
EY13.51%
EPS(NY)2.57
Fwd EY16.31%
FCF(TTM)2.45
FCFY15.51%
OCF(TTM)3.22
OCFY20.45%
SpS48.73
BVpS-4.98
TBVpS-9
PEG (NY)0.36
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.53%
GM 77.87%
FCFM 5.02%
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)29.25%
ROCE(5y)32.45%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
F-Score6
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Debt/EBITDA N/A
Cap/Depr 66.34%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 110.78%
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.16
F-Score6
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)95.33%
Cap/Depr(5y)112.44%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.46%
Profit Quality(3y)110.5%
Profit Quality(5y)92.32%
High Growth Momentum
Growth
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%
Revenue Next Year4.67%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.85%
EBIT growth 3Y-4.2%
EBIT growth 5Y-4.89%
EBIT Next Year36.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.77%
FCF growth 3Y8.85%
FCF growth 5Y-13.31%
OCF growth 1Y16.78%
OCF growth 3Y-1.85%
OCF growth 5Y-11.92%

HERBALIFE LTD / HLF FAQ

Can you provide the ChartMill fundamental rating for HERBALIFE LTD?

ChartMill assigns a fundamental rating of 4 / 10 to HLF.


What is the valuation status for HLF stock?

ChartMill assigns a valuation rating of 8 / 10 to HERBALIFE LTD (HLF). This can be considered as Undervalued.


What is the profitability of HLF stock?

HERBALIFE LTD (HLF) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HERBALIFE LTD (HLF) stock?

The Price/Earnings (PE) ratio for HERBALIFE LTD (HLF) is 7.4 and the Price/Book (PB) ratio is -3.16.


What is the earnings growth outlook for HERBALIFE LTD?

The Earnings per Share (EPS) of HERBALIFE LTD (HLF) is expected to grow by 20.74% in the next year.